| scholarly article | Q13442814 |
| P50 | author | Khalequ Zaman | Q92781211 |
| Mark C Steinhoff | Q104746474 | ||
| Gretchen C. Langdon | Q127461305 | ||
| Helen Y. Chu | Q57061229 | ||
| Janet Englund | Q66733209 | ||
| Amalia S Magaret | Q87912727 | ||
| P2093 | author name string | Edward E Walsh | |
| Eliza Roy | |||
| Mary Anne Formica | |||
| P2860 | cites work | A nearly continuous measure of birth weight for gestational age using a United States national reference | Q24792528 |
| Global burden of childhood pneumonia and diarrhoea | Q28288886 | ||
| Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes. | Q30354456 | ||
| The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya | Q30941156 | ||
| The transplacental transfer of IgG subclasses: influence of prematurity and low birthweight in the Gambian population | Q31125958 | ||
| Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia | Q34376358 | ||
| Challenges to evaluating respiratory syncytial virus mortality in Bangladesh, 2004-2008. | Q34568223 | ||
| The burden of respiratory syncytial virus infection in young children | Q34938343 | ||
| Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States. | Q35227247 | ||
| High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody | Q36055407 | ||
| Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats | Q36903965 | ||
| Reducing mortality from childhood pneumonia and diarrhoea: The leading priority is also the greatest opportunity | Q36978046 | ||
| Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. | Q37205945 | ||
| Strategic priorities for respiratory syncytial virus (RSV) vaccine development | Q37572640 | ||
| Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis | Q37955413 | ||
| Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. | Q38090932 | ||
| Incidence of influenza virus infection in early infancy: a prospective study in South Asia | Q39063952 | ||
| The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae | Q39945762 | ||
| Effectiveness of maternal influenza immunization in mothers and infants | Q40409398 | ||
| Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women | Q40555244 | ||
| Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort | Q41875572 | ||
| Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults | Q43979004 | ||
| Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants | Q44078770 | ||
| Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze | Q45387793 | ||
| Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus | Q45392073 | ||
| The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease | Q45397091 | ||
| Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies | Q45722681 | ||
| Seroepidemiological study of respiratory syncytial virus in São Paulo state, Brazil | Q45755561 | ||
| Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly | Q45760956 | ||
| Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection | Q45763369 | ||
| Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. | Q45765792 | ||
| Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level | Q45792098 | ||
| Maternal antibody and respiratory syncytial virus infection in infancy | Q45793140 | ||
| Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection | Q45819346 | ||
| Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children | Q45888997 | ||
| Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants | Q72888261 | ||
| Maternal immunization against viral disease | Q77122444 | ||
| Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants | Q77183363 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Bangladesh | Q902 |
| maternal health | Q6786626 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1582-1589 | |
| P577 | publication date | 2014-06-05 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh | |
| P478 | volume | 210 |
| Q101126113 | A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK-1654 in Healthy Adults |
| Q41060727 | A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. |
| Q36194104 | Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya |
| Q33809443 | Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection |
| Q90068187 | Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus |
| Q38883748 | Antibiotic consumption by New Zealand children: exposure is near universal by the age of 5 years |
| Q46987999 | Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy |
| Q59354557 | Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness. |
| Q35915613 | Burden of Influenza and Respiratory Syncytial Virus Infection in Pregnant Women and Infants Under 6 Months in Mongolia: A Prospective Cohort Study |
| Q38938594 | Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop |
| Q36263882 | Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age |
| Q40060039 | Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States |
| Q35975363 | Clinical Presentation and Birth Outcomes Associated with Respiratory Syncytial Virus Infection in Pregnancy |
| Q91991655 | Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women |
| Q90521301 | Comparisons of Antibody Populations in Different Pre-Fusion F VLP-Immunized Cotton Rat Dams and Their Offspring |
| Q26764790 | Determinants of early life immune responses to RSV infection |
| Q35986962 | Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus |
| Q55079643 | Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model. |
| Q50317606 | Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf |
| Q89724631 | Evaluation of respiratory syncytial virus IgG antibody dynamics in mother-infant pairs cohort |
| Q64060972 | Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease |
| Q39256577 | Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis. |
| Q36440236 | Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea |
| Q90681995 | Impact of Respiratory Syncytial Virus Infection on the Host Cell: Implications for Antiviral Strategies |
| Q38631747 | In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants. |
| Q38589021 | Maternal benefits of immunization during pregnancy |
| Q90356741 | Maternal immunisation to improve the health of HIV-exposed infants |
| Q39256585 | Maternal immunisation: collaborating with mother nature |
| Q59357846 | Maternal immunization with a recombinant adenovirus-expressing fusion protein protects neonatal cotton rats from respiratory syncytia virus infection by transferring antibodies via breast milk and placenta |
| Q101137473 | Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity |
| Q37501634 | Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy |
| Q91811288 | Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine |
| Q41441320 | Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs |
| Q89884849 | Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation |
| Q39303791 | Ongoing developments in RSV prophylaxis: a clinician's analysis |
| Q39318498 | Passive and active immunization against respiratory syncytial virus for the young and old. |
| Q59358180 | Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy |
| Q42652733 | Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV. |
| Q45326381 | Prefusion F, postfusion F, G antibodies and disease severity in infants and young children with acute respiratory syncytial virus infection |
| Q36665660 | Progress toward a Respiratory Syncytial Virus Vaccine |
| Q35223733 | Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya |
| Q45323940 | Respiratory syncytial virus seasonality and its implications on prevention strategies. |
| Q58791847 | Risk factors for bronchiolitis severity: A retrospective review of patients admitted to the university hospital from central region of Slovenia |
| Q38604949 | Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention |
| Q52699604 | Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials. |
| Q38819027 | Strategies to develop vaccines of pediatric interest |
| Q45323691 | The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years |
| Q100500929 | The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother-neonate cohort study |
| Q45324418 | Timing of First Respiratory Virus Detections in Infants: A Community-Based Birth Cohort Study |
| Q40043300 | Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal |
| Q59356158 | Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy |
| Q38660842 | Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis. |
| Q38868960 | Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality? |
| Q30371409 | Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh. |
Search more.